ParkerVision Q2 net loss $1.6M; patent litigation updates on Qualcomm, Realtek, MediaTek

PARKERVISION INC

Net loss $1.6M for Q2 2025 ($0.01/share) vs $0.3M loss in Q2 2024; H1 2025 loss $5.4M ($0.05/share).
Operating expenses surged 69% due to $2.5M non-cash charge from extending executive stock options to January 2031.
Cash used in operations $3.0M in H1; cash balance $2.05M at quarter end.
Qualcomm case: court issued third claim construction order; ParkerVision plans to appeal and seeks final judgment on receiver claims.
Realtek trial set Jan 2026, MediaTek trial Mar 2026; TI and NXP cases stayed pending PTAB IPR decisions expected Nov 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.